Trial record 1 of 1 for:    NCT01866826
Previous Study | Return to List | Next Study

Rifaximin for Chronic Immune Activation in People With HIV

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01866826
Recruitment Status : Active, not recruiting
First Posted : June 3, 2013
Last Update Posted : January 25, 2017
National Institute of Allergy and Infectious Diseases (NIAID)
University of Pittsburgh
Walter Reed Navy MMC
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )